Correlation Between Dimerix and Effector Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dimerix and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dimerix and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dimerix and Effector Therapeutics, you can compare the effects of market volatilities on Dimerix and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dimerix with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dimerix and Effector Therapeutics.

Diversification Opportunities for Dimerix and Effector Therapeutics

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Dimerix and Effector is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Dimerix and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Dimerix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dimerix are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Dimerix i.e., Dimerix and Effector Therapeutics go up and down completely randomly.

Pair Corralation between Dimerix and Effector Therapeutics

Assuming the 90 days trading horizon Dimerix is expected to generate 27.77 times less return on investment than Effector Therapeutics. But when comparing it to its historical volatility, Dimerix is 12.64 times less risky than Effector Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Effector Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  0.02  in Effector Therapeutics on September 7, 2025 and sell it today you would earn a total of  0.00  from holding Effector Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Dimerix  vs.  Effector Therapeutics

 Performance 
       Timeline  
Dimerix 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Dimerix are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Dimerix may actually be approaching a critical reversion point that can send shares even higher in January 2026.
Effector Therapeutics 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Effector Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Effector Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Dimerix and Effector Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dimerix and Effector Therapeutics

The main advantage of trading using opposite Dimerix and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dimerix position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.
The idea behind Dimerix and Effector Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk